Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 3 of 3 for “"뉴로파이브로민"”.

  1. Studies on the Mechanisms of Malignant Transformation in Neurofibromatosis Type 1

    "신경섬유종증 제1형(Neurofibromatosis Type 1, NF1)은 1882년 Fredrich von Recklin-ghausen이 처음 기술하였으며, 말초신경을 따라 다기관에 다발적으로 종양을 형성하는 상염색체 우성 유전 질환으로 약 3500명중 1명꼴로 발생한다. NF1은 NF1 유전자의 돌연변이에 의해 발병하며, 환자의 약 50%는 유전이 아닌 자연발생적인 돌연변이에 의해 발생한다. 환자의 약 10%에서는 높은 사망률과 화학요법과 방사능에 낮은 반응을 보이는 malignant peripheral nerve …

    ajou Repository record for Studies on the Mechanisms of Malignant Transformation in Neurofibromatosis Type 1 (opens in a new tab)

  2. Studies on the Molecular Mechanisms of Tumorigenesis in Neurofibromatosis Type 1

    Neurofibromatosis type 1 (NF1) is one of the most common inherited autosomal dominant disorders, with an estimated incidence of 1 per 3,500 births. NF1 is characterized by a high incidence of benign and malignant tumors attributed to loss of function of NF1. NF1 gene encodes neurofibromin, a tumor …

    ajou Repository record for Studies on the Molecular Mechanisms of Tumorigenesis in Neurofibromatosis Type 1 (opens in a new tab)

  3. The Role of Bcl-xL and EGFR in the Malignant Progression of Neurofibromatosis type 1

    Neurofibromatosis Type 1 (NF1) is one of the most commonly inherited autosomal dominant human genetic disorders, with an incidence of approximately 1 in 3000~3500 individuals worldwide. NF1 is caused by loss-of-function mutations in the NF1 gene encoding neurofibromin, a GTPase-activating protein …

    ajou Repository record for The Role of Bcl-xL and EGFR in the Malignant Progression of Neurofibromatosis type 1 (opens in a new tab)